✦ LIBER ✦

Phase II study of second-line treatment with high-dose cyclophosphamide in recurrent metastatic breast cancer

✍ Scribed by Flemming Hansen; Peter Møller; Torben Skovsgaard

Publisher: Springer
Year: 1996
Tongue: English
Weight: 216 KB
Volume: 37
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800050400

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine and vinorelbine as second-li

Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study

✍ Michela Donadio; Mara Ardine; Alfredo Berruti; Giuliana Ritorto; Elena Fea; Mari 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 179 KB

A phase I/II study of high-dose megestro

A phase I/II study of high-dose megestrol acetate in the treatment of metastatic breast cancer

✍ Howard L. Parnes; Jeffrey S. Abrams; N. Simon Tchekmedyian; Nancy Tait; Joseph A 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 543 KB

Phase II study of low dose cyclophospham

Phase II study of low dose cyclophosphamide and intravenous interleukin-2 in metastatic renal cancer

✍ Walter D. Y. Quan; Grace E. Dean; Gary Lieskovsky; Malcolm S. Mitchell; Raymond 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 384 KB

Phase II study of ionidamine in patients

Phase II study of ionidamine in patients with metastatic breast cancer

✍ H. Ian Robins; Donna S. Neuberg; Al B. Benson; Kishan J. Pandya; Douglass C. Tor 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 193 KB

The Eastern Cooperative Oncology Group conducted a phase II study of lonidamine in patients with metastatic breast cancer. The drug was given orally to a maximum daily dose of 340 mg/m 2. Forty-two patients were entered on study. One partial response was observed; there were no life-threatening toxi

A phase II trial of docetaxel (Taxotere®

A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancer

✍ Martina Baur; Allan T. van Oosterom; Véronique Diéras; Michele Tubiana-Hulin; R. 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 385 KB

Phase I–II study of high-dose etoposide

Phase I–II study of high-dose etoposide in patients with refractory breast cancer

✍ Giuseppe Fraschini; Frankie A. Holmes; Laura Esparza; Richard L. Theriault; Aman 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 162 KB